| Microfluidic cell culture M Mehling, S Tay Current opinion in Biotechnology 25, 95-102, 2014 | 454 | 2014 |
| FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis M Mehling, V Brinkmann, J Antel, A Bar-Or, N Goebels, C Vedrine, ... Neurology 71 (16), 1261-1267, 2008 | 396 | 2008 |
| Lack of association between antimyelin antibodies and progression to multiple sclerosis J Kuhle, C Pohl, M Mehling, G Edan, MS Freedman, HP Hartung, ... New England Journal of Medicine 356 (4), 371-378, 2007 | 301 | 2007 |
| A PD‐1 polymorphism is associated with disease progression in multiple sclerosis A Kroner, M Mehling, B Hemmer, P Rieckmann, KV Toyka, M Mäurer, ... Annals of neurology 58 (1), 50-57, 2005 | 291 | 2005 |
| Altered expression of miR‐17‐5p in CD4+ lymphocytes of relapsing–remitting multiple sclerosis patients RLP Lindberg, F Hoffmann, M Mehling, J Kuhle, L Kappos European journal of immunology 40 (3), 888-898, 2010 | 243 | 2010 |
| Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis J Kuhle, RLP Lindberg, A Regeniter, M Mehling, AJ Steck, L Kappos, ... European journal of neurology 16 (6), 771-774, 2009 | 222 | 2009 |
| Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis M Mehling, R Lindberg, F Raulf, J Kuhle, C Hess, L Kappos, V Brinkmann Neurology 75 (5), 403-410, 2010 | 217 | 2010 |
| Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis L Kappos, M Mehling, R Arroyo, G Izquierdo, K Selmaj, V Curovic-Perisic, ... Neurology 84 (9), 872-879, 2015 | 167 | 2015 |
| Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis J Kuhle, D Leppert, A Petzold, A Regeniter, C Schindler, M Mehling, ... Neurology 76 (14), 1206-1213, 2011 | 167 | 2011 |
| Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis M Mehling, TA Johnson, J Antel, L Kappos, A Bar-Or Neurology 76 (8_supplement_3), S20-S27, 2011 | 166 | 2011 |
| Advances in oral immunomodulating therapies in relapsing multiple sclerosis T Derfuss, M Mehling, A Papadopoulou, A Bar-Or, JA Cohen, L Kappos The Lancet Neurology 19 (4), 336-347, 2020 | 104 | 2020 |
| Antigen‐specific adaptive immune responses in fingolimod‐treated multiple sclerosis patients M Mehling, P Hilbert, S Fritz, B Durovic, D Eichin, O Gasser, J Kuhle, ... Annals of neurology 69 (2), 408-413, 2011 | 94 | 2011 |
| A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein J Kuhle, A Regeniter, D Leppert, M Mehling, L Kappos, RLP Lindberg, ... Journal of neuroimmunology 220 (1-2), 114-119, 2010 | 94 | 2010 |
| The immune-metabolic basis of effector memory CD4+ T cell function under hypoxic conditions S Dimeloe, M Mehling, C Frick, J Loeliger, GR Bantug, U Sauder, ... The Journal of Immunology 196 (1), 106-114, 2016 | 93 | 2016 |
| A microfluidic device for measuring cell migration towards substrate-bound and soluble chemokine gradients J Schwarz, V Bierbaum, J Merrin, T Frank, R Hauschild, T Bollenbach, ... Scientific reports 6 (1), 36440, 2016 | 81 | 2016 |
| Fingolimod for multiple sclerosis: mechanism of action, clinical outcomes, and future directions M Mehling, L Kappos, T Derfuss Current neurology and neuroscience reports 11, 492-497, 2011 | 80 | 2011 |
| Locally triggered release of the chemokine CCL21 promotes dendritic cell transmigration across lymphatic endothelia K Vaahtomeri, M Brown, R Hauschild, I De Vries, AF Leithner, M Mehling, ... Cell reports 19 (5), 902-909, 2017 | 79 | 2017 |
| A modern approach to CSF analysis: pathophysiology, clinical application, proof of concept and laboratory reporting A Regeniter, J Kuhle, M Mehling, H Möller, U Wurster, H Freidank, ... Clinical neurology and neurosurgery 111 (4), 313-318, 2009 | 77 | 2009 |
| Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF J Kuhle, RLP Lindberg, A Regeniter, M Mehling, F Hoffmann, M Reindl, ... Journal of neurology 254, 160-168, 2007 | 67 | 2007 |
| WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism? M Mehling, P Simon, M Mittelbronn, R Meyermann, S Ferrone, M Weller, ... Acta neuropathologica 114, 111-119, 2007 | 66 | 2007 |
